2024-12-14 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**1. Performance Comparison & Overview:**

Colgate-Palmolive Co (CL) is a consumer goods company that manufactures and markets oral hygiene products, personal care products, and pet nutrition products globally.

As of the last data point, CL's cumulative return is 43.13%, significantly lagging behind the S&P 500's (VOO) cumulative return of 120.91%.  The difference is -77.8%, placing it at the 2.5th percentile of its historical range of performance relative to the S&P 500 (-80.0% to 8.2%).  This indicates substantial underperformance compared to the broader market.

The provided CAGR data shows inconsistent performance over different time periods, ranging from -12% to 32%.  Alpha consistently remains around 0.2, suggesting a slight outperformance relative to the market after accounting for beta, though this is overshadowed by the cumulative underperformance. Beta generally hovers around 0.2, indicating low market sensitivity.  Market capitalization fluctuates between $42B and $76B.

**2. Recent Price Movement:**

* **Closing Price:** $93.44
* **5-Day Moving Average:** $93.32
* **20-Day Moving Average:** $94.63
* **60-Day Moving Average:** $96.79

The stock price is currently trading below its 5, 20, and 60-day moving averages, suggesting a bearish short-term trend.  The relatively small difference between the closing price and the last market price suggests minimal intraday volatility.

**3. Technical Indicators & Expected Return:**

* **RSI:** 43.02 – This indicates the stock is currently in oversold territory.
* **PPO:** -0.09 – A negative value suggests bearish momentum.
* **20-Day Relative Divergence:** +0.7 – Indicates a recent short-term upward trend.

Given the closing price of $93.45, there's no significant indication of a sudden spike or drop in price based on the information provided.  The expected return is 0.0%.  The provided information does not give a concrete projection for long-term (2+ years) outperformance relative to the S&P 500 beyond noting historical underperformance.  More comprehensive forecasting models are required for such a projection.


**4. Recent Earnings Analysis:**

The most recent quarterly results show a slight decline in both EPS and revenue compared to the preceding quarter (Q2 2024).  While revenue has remained relatively stable around $5B, EPS has gradually decreased from $0.9 to $0.86 over the last two quarters. The provided data lacks context on whether these figures met or missed analyst expectations.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has remained relatively stable over the past year, though it slightly decreased in the most recent quarter.  Profit margins have gradually decreased over the past year.

* **Capital and Profitability:**  Equity and ROE figures show significant volatility.  The high variability in ROE indicates considerable fluctuation in profitability and financial leverage.  The negative ROE in Q3 2023 (-7866.67%) warrants further investigation into the underlying causes.  The very high ROE values in Q1 and Q2 of 2024 are also notable and need further investigation beyond the data provided.

**6. News and Recent Issues:**

No recent (within the last two days) earnings news is explicitly provided.  There is no information regarding market outlook or analyst opinions.  Additional information is needed in this section for a complete analysis.

**7. Overall Analysis:**

Colgate-Palmolive (CL) shows significant underperformance against the S&P 500 over the observed period, despite showing relatively low market sensitivity (beta).  Recent price action suggests a short-term bearish trend, though RSI suggests potential for a rebound.  Earnings have shown some weakening in recent quarters, and financial statements highlight considerable volatility in key metrics.  The lack of recent news and analyst opinions limits the scope of this analysis.  Further investigation into the causes of the volatile ROE and the reasons for the recent EPS decline is crucial for a thorough evaluation of the stock's prospects.  More context is needed on whether earnings met or missed expectations, and whether analyst opinions support the current trend.


**8. Disclaimer:** This report is based solely on the data provided. It does not constitute financial advice, and readers should conduct thorough independent research and consider their own risk tolerance before making any investment decisions.
